ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

260 hedge funds and large institutions have $6.22B invested in Alnylam Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 98 increasing their positions, 75 reducing their positions, and 39 closing their positions.

Holders
260
Holders Change
+3
Holders Change %
+1.17%
% of All Funds
6.83%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.18%
New
44
Increased
98
Reduced
75
Closed
39
Calls
$21M
Puts
$25.4M
Net Calls
-$4.4M
Net Calls Change
-$20.5M

Top Buyers

1
Baillie Gifford & Co
1
Baillie Gifford & Co
United Kingdom
$257M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$475M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$1B
4
ACH
4
ArrowMark Colorado Holdings
Colorado
$16.6M
5
SPC
5
Slate Path Capital
New York
$68.3M

Top Sellers

1
AAMU
1
Amundi Asset Management US
Massachusetts
$0
2
First Trust Advisors
2
First Trust Advisors
Illinois
$115M
3
UIM
3
USS Investment Management
United Kingdom
$0
4
CCM
4
Camber Capital Management
Massachusetts
$0
5
GTP
5
Global Thematic Partners
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.2B 12,710,356 +18,087 +0.1%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$1B 10,657,484 +333,358 +3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$475M 5,048,221 +416,709 +9%
Baillie Gifford & Co
4
Baillie Gifford & Co
United Kingdom
$257M 2,727,734 +2,018,484 +285%
Capital World Investors
5
Capital World Investors
California
$183M 1,938,603 -5,000 -0.3%
UBS AM
6
UBS AM
Illinois
$181M 1,921,276 +9,741 +0.5%
BIT
7
BlackRock Institutional Trust
California
$167M 1,772,889 +11,275 +0.6%
BFA
8
BlackRock Fund Advisors
California
$162M 1,726,124 -177,587 -9%
State Street
9
State Street
Massachusetts
$158M 1,673,737 +126,382 +8%
Jennison Associates
10
Jennison Associates
New York
$140M 1,489,541 +7,296 +0.5%
GGHC
11
Gilder Gagnon Howe & Co
New York
$139M 1,477,367 -16,480 -1%
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$117M 1,237,845 -82,350 -6%
First Trust Advisors
13
First Trust Advisors
Illinois
$115M 1,223,535 -338,836 -22%
BB
14
BB Biotech
Switzerland
$107M 1,132,499 – –
Morgan Stanley
15
Morgan Stanley
New York
$103M 1,096,925 -115,371 -10%
BRC
16
Blue Ridge Capital
New York
$101M 1,075,000 – –
Franklin Resources
17
Franklin Resources
California
$91.1M 967,825 +29,200 +3%
Wells Fargo
18
Wells Fargo
California
$72.9M 774,236 -2,640 -0.3%
SPC
19
Slate Path Capital
New York
$68.3M 725,000 +130,000 +22%
BM
20
Bridger Management
New York
$67.5M 717,521 +5,132 +0.7%
1WCM
21
12 West Capital Management
New York
$61.3M 651,000 – –
Norges Bank
22
Norges Bank
Norway
$56.3M 598,157 -66,811 -10%
RI
23
RTW Investments
New York
$54M 573,361 +39,701 +7%
AWG
24
Alpha Wave Global
New York
$46.3M 491,713 – –
AG
25
Artal Group
Luxembourg
$44.7M 475,000 +40,000 +9%
1
2 3 4 5